Tucker G T, Mather L E
Clin Pharmacokinet. 1979 Jul-Aug;4(4):241-78. doi: 10.2165/00003088-197904040-00001.
The introduction of the new long acting local anaesthetics, bupivacaine and etidocaine, has stimulated an expansion of interest in regional anaesthesia, particularly for obstetrical applications and pain therapy. System toxicity following injection of local anesthetics occurs albeit infrequently, and tentative correlations have been made between the onset of CNS and cardiovascular effects and circulating drug concentrations in both adults and neonates. Amongst other factors, interpretation of these relationships depends upon blood distribution and plasma binding of the agents, sampling sites and acid-base balance. The disposition kinetics and placental transfer of the amide type agents have been well characterised. In adults their clearance is almost entirely hepatic but in neonates an increase in the renal component is, in part, a reflection of the immaturity of some of the enzymes responsible for their metabolism. Ester type agents are rapidly hydrolysed by plasma pseudocholinesterase and this has led to a preference for chloroprocaine in some obstetric procedures. Major determinants of the systemic absorption of the agents after perineural administration include their physicochemical and vasoactive properties, perfusion and tissue binding at the site of injection and whether or not adrenaline has been added. In respect of blood drug concentrations achieved after various regional anaesthetic procedures, the margin of systemic safety appears to favour bupivacaine and etidocaine compared to shorter acting analogues such as lignocaine and mepivacaine. The time course of local anaesthetic remaining at the site of injection has been calculated following intravenous regional anaesthesia and peridural block. This has allowed prediction of the local and systemic accumulation of the drugs following contined dosage. Blood concentrations of local anaesthetics after perineural injection are not closely related to age, weight or pregnancy but may be influenced by diseases associated with haemodynamic changes and by other drugs given at or around the time of regional blockade.
新型长效局部麻醉药布比卡因和依替卡因的引入,激发了人们对区域麻醉的兴趣,尤其是在产科应用和疼痛治疗方面。局部麻醉药注射后虽偶有发生全身毒性反应,但已在成人和新生儿中对中枢神经系统及心血管效应的发作与循环药物浓度之间建立了初步关联。在其他因素中,这些关系的解读取决于药物的血液分布和血浆结合、采样部位以及酸碱平衡。酰胺类药物的处置动力学和胎盘转运已得到充分表征。在成人中,它们的清除几乎完全通过肝脏,但在新生儿中,肾脏清除成分的增加部分反映了负责其代谢的某些酶的不成熟。酯类药物可被血浆假性胆碱酯酶迅速水解,这使得在一些产科手术中更倾向于使用氯普鲁卡因。神经周围给药后药物全身吸收的主要决定因素包括其物理化学和血管活性特性、注射部位的灌注和组织结合以及是否添加了肾上腺素。就各种区域麻醉手术后达到的血药浓度而言,与利多卡因和甲哌卡因等短效类似物相比,全身安全性似乎更倾向于布比卡因和依替卡因。静脉区域麻醉和硬膜外阻滞术后,已计算出局部麻醉药在注射部位残留的时间进程。这使得能够预测持续给药后药物的局部和全身蓄积情况。神经周围注射后局部麻醉药的血药浓度与年龄、体重或妊娠无关,但可能受与血流动力学变化相关的疾病以及区域阻滞时或其前后给予的其他药物的影响。